The Journal of Experimental Medicine
VeriKine-HS Human IFN-Beta
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef

Index of Online Supplemental Material for
J. Exp. Med. 10.1084/jem.20071211
Kwissa et al.

Figure S1 Experimental design. Each experimental group consisted of five animals, as indicated in Table I.

Figure S2 T cell gating strategy.

Figure S3 Qualities of Gag-specific T cells after a second rMVA boost vaccination.

Figure S4 Quality of Gag-specific CD4+ T cells after SIV challenge.

Figure S5 Frequency of CD4+ T cells in the intestine after SIV challenge.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article
Right arrow Alert me to new content in the JEM
Citing Articles
Right arrow Citing Articles via CrossRef


  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS